Quanterix Corporation Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. The...
Entry price: 79.93 Fundamentals : - Sector: Medical Products - EPS % Chg (Last Qtr): 118% - EPS % Chg (Previous Qtr): -6% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 110% - Sales % Chg (Previous Qtr): -3% - 3-Year Sales Growth Rate: 51% - Annual Pre -Tax Margin: -72.2%
Bullish Pennant Pros: Descending volume during formation PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 9 200MA ascending 250RSI below 50 If confirmed: PT = 119.48$
Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test As case counts and positivity rates rise globally, the COVID-19 testing landscape is of critical importance finance.yahoo.com
Constant Higher lows after finding support along the 50 MA. Broke trendline and good bounce today.
Attempting to clear overhead resistance range of $48/49, with some volume over the last few sessions.
this stock has been in a up trend every time it pulls back to the 50 day SMA it has broke and headed north this stock has pulled back to the up trend line if it breaks the down trend line and closes above this could push up to 62.48 area at its 1.618 fib ext. with a stop of a break below the 50 day and close below or break below the up trend line that it has...
Low risk long at the retest zone of 28.85 - 29.10
All description on the chart. Please, don't forget to like and follow. Thank you.
Quality breakout after a long consolidation, within a longer term uptrend. I need nothing else to double down on this one. Full disclosure: with today's buy at the open, I'm now long QTRX at 0.9% of total assets.
QTRX formed its long term bullish channel since September 2018 and now its on it's support area and it is now going up. There is a probability the price would reach its resistance at $27 soon.
Clue: It is one of the most over-used and misguided technical patterns referenced on tradingview. If this company starts to hit milestones and execute with its disruptive biotech plans, this stock is an easy double in very short order.